Gilead to buy Immunomedics for $21bn
admin 14th September 2020 Uncategorised 0The move adds Trodelvy, a first-in-class antibody-drug conjugate approved to treat triple-negative breast cancer, to the drugmaker’s portfolio More: Gilead to buy Immunomedics for bn Source: News
read more